Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1143/UN14.2.2.VII.14/LT/2020 | Other Identifier | Committee of Ethical Research of Udayana University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The effects of anesthesia and surgery can lead to stress responses that result in hormonal and metabolic changes in the body. The immune system and the nervous system communicate both ways, and it was found that nociception and proinflammatory cytokines play a joint regulatory role, i.e., increased production of proinflammatory cytokines can worsen the pain. Major surgery can trigger the release of cytokines such as IL-1, IL-6, and TNF-α.
The effects of anesthesia and surgery can lead to stress responses that result in hormonal and metabolic changes in the body. The immune system and the nervous system communicate both ways, and it was found that nociception and proinflammatory cytokines play a joint regulatory role, i.e., increased production of proinflammatory cytokines can worsen the pain. Major surgery can trigger the release of cytokines such as IL-1, IL-6, and TNF-α.
The acute analgesic effect of ketamine is generally believed to be mediated through the blockade of the phencyclidine binding site of the N-methyl-d-aspartate (NMDA) receptor of nociceptive neurons. Ketamine can reduce the inflammatory response marked by a decrease in CRP levels to surgical trauma and can prevent secondary damage to tissues/organs that were not initially affected by surgery by reducing inflammation. This also reduces postoperative pain and analgesics.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| End-of-surgery | Active Comparator | Low-dose ketamine (0.3 mg/kg) in 3 ml normal saline solution given at the end of surgery |
|
| Induction | Placebo Comparator | Low-dose ketamine (0.3 mg/kg) in 3 ml normal saline solution given at induction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ketamine 0.3 mg/kg at end-of-surgery | Drug | Ketamine 0.3 mg/kg at end-of-surgery (intravenously) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Serum CRP level | Serum C-reactive protein level | 1-hour before surgery |
| Serum CRP level | Serum C-reactive protein level | 24-hours after surgery |
| serum neutrophil-count | serum neutrophil-count (from a complete blood count test) | 1-hour before surgery |
| serum neutrophil-count | serum neutrophil-count (from a complete blood count test) | 24-hours after surgery |
| VAS (visual analog score) | minimum=0; maximum=10; higher score corresponds to more severe pain | first 24 hours after the surgery |
| morphine consumption (mg) | total morphine consumption in 24 hours after the surgery | first 24 hours after the surgery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Drop Out Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tjokorda GA Senapathi, Dr | Udayana University | Study Chair |
| Christopher Ryalino, Dr | Udayana University | Principal Investigator |
| Made SP Adi, Dr | Udayana University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sanglah General Hospital | Denpasar | Bali | 80114 | Indonesia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a double-blind, randomized control trial. It provides a controlled care comparison between low-dose ketamine given at anesthesia induction and at the end-of-surgery.
Not provided
Not provided
Only care providers involved directly with the subjects in the operating room are not masked.
| Ketamine 0.3 mg/kg at anesthesia induction | Drug | Ketamine 0.3 mg/kg at anesthesia induction (intravenously) |
|
|
| ID | Term |
|---|---|
| D007249 | Inflammation |
| D015775 | Fractures, Stress |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D050723 | Fractures, Bone |
| D014947 | Wounds and Injuries |
Not provided
Not provided
| ID | Term |
|---|---|
| D007649 | Ketamine |
| ID | Term |
|---|---|
| D003510 | Cyclohexanes |
| D003516 | Cycloparaffins |
| D006840 | Hydrocarbons, Alicyclic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
Not provided
Not provided